FDA Panel Nixes Novel Alzheimer ' s Therapy FDA Panel Nixes Novel Alzheimer ' s Therapy

An FDA advisory panel questions the evidence showing beneficial effects of a therapy that combines transcranial magnetic stimulation with cognitive training.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news